Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2002 1
2004 2
2007 2
2010 1
2013 2
2014 2
2015 3
2016 4
2017 2
2018 4
2019 8
2020 9
2021 2
2022 5
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
Giovannoni G, Boyko A, Correale J, Edan G, Freedman MS, Montalban X, Rammohan K, Stefoski D, Yamout B, Leist T, Aydemir A, Borsi L, Verdun di Cantogno E. Giovannoni G, et al. Among authors: aydemir a. Mult Scler. 2023 May;29(6):719-730. doi: 10.1177/13524585231161494. Epub 2023 Apr 3. Mult Scler. 2023. PMID: 37012898 Free PMC article.
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.
Giovannoni G, Boyko A, Correale J, Edan G, Freedman MS, Montalban X, Rammohan K, Stefoski D, Yamout B, Leist T, Aydemir A, Borsi L, di Cantogno EV. Giovannoni G, et al. Among authors: aydemir a. Neurodegener Dis Manag. 2023 Oct;13(5):261-268. doi: 10.2217/nmt-2023-0018. Epub 2023 Aug 3. Neurodegener Dis Manag. 2023. PMID: 37535336 Free article. Review.
A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach.
Rochester L, Mazzà C, Mueller A, Caulfield B, McCarthy M, Becker C, Miller R, Piraino P, Viceconti M, Dartee WP, Garcia-Aymerich J, Aydemir AA, Vereijken B, Arnera V, Ammour N, Jackson M, Hache T, Roubenoff R. Rochester L, et al. Among authors: aydemir aa. Digit Biomark. 2020 Nov 26;4(Suppl 1):13-27. doi: 10.1159/000512513. eCollection 2020 Winter. Digit Biomark. 2020. PMID: 33442578 Free PMC article. Review.
TRENDS IN UNICOMPARTMENTAL KNEE ARTHROPLASTY.
Aydemir AN, Yucens M. Aydemir AN, et al. Acta Ortop Bras. 2020 Jan-Feb;28(1):19-21. doi: 10.1590/1413-785220202801222851. Acta Ortop Bras. 2020. PMID: 32095107 Free PMC article.
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.
Butzkueven H, Hillert J, Soilu-Hänninen M, Ziemssen T, Kuhle J, Wergeland S, Magyari M, Berger JR, Moore N, Aydemir A, Bezemer I, Sabidó M. Butzkueven H, et al. Among authors: aydemir a. Curr Med Res Opin. 2023 Oct;39(10):1367-1374. doi: 10.1080/03007995.2023.2256220. Epub 2023 Sep 7. Curr Med Res Opin. 2023. PMID: 37675878
A rare rib lesion due to parosteal osteosarcoma: a case report.
Tozum H, Aydemir AN, Demiroglu M, Ozkan K, Ceyran AB, Kılıc B. Tozum H, et al. Among authors: aydemir an. J Med Case Rep. 2019 Jan 23;13(1):19. doi: 10.1186/s13256-018-1958-7. J Med Case Rep. 2019. PMID: 30670083 Free PMC article.
55 results